Skip to main content
Signal8

RELX PLC (RELX)

RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.

Sector: Services-Business Services, NEC

Industry: Specialty Business Services

RELX Plc logo

RELX Plc

NYSE:RELXIndustrials
-3.09%$40.17
CLOSED
AH$40.17+0.00%vs close
Mkt Cap$69.71B
Float1.68B
O/S1.74B
VOL2.09M sh
$ Vol$83.87M
RVOL0.82×
Inst Own4.9%
SI0.3%
Div Yield2.28%
Dilution
RELX Plc logoNYSE:RELXClosed$40.17-3.09%
  • AI analysis ›